Paul Choi
Stock Analyst at Goldman Sachs
(0)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
URGN UroGen Pharma | Maintains: Neutral | 16 3 | 14.31 | -79.04% | 4 | May 22, 2025 | |
GOSS Gossamer Bio | Maintains: Strong Buy | 7 8 | 1.36 | 488.24% | 6 | May 16, 2025 | |
PHAT Phathom Pharmaceutic... | Maintains: Neutral | 10 5 | 9.49 | -47.31% | 10 | May 2, 2025 | |
ARVN Arvinas | Maintains: Neutral | 12 8 | 7.39 | 8.25% | 3 | May 2, 2025 | |
XENE Xenon Pharmaceutical... | Maintains: Buy | 60 52 | 31.47 | 65.24% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 5.04 | 316.67% | 8 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 12 | 7.84 | 53.06% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 1.04 | 188.46% | 9 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 12 10 | 9.73 | 2.77% | 4 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 20 7 | 12.62 | -44.53% | 7 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 225 | 175.73 | 28.04% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 143 | 80.78 | 77.02% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 42 | 49.56 | -15.25% | 7 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 85 60 | 32.59 | 84.11% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 19 | 15.2 | 25% | 6 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 32 | 28.7 | 11.5% | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 29 50 | 42.12 | 18.71% | 6 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 19 | 4.9 | 287.76% | 3 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 400 50 | 5.45 | 817.43% | 7 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 29 26 | n/a | n/a | 2 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 4 | n/a | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 25 | 1.07 | 2236.45% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 450 100 | n/a | n/a | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 4 | n/a | n/a | 4 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 4 | n/a | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 151 170 | 14.43 | 1078.1% | 2 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 225 125 | n/a | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 9 8 | 3.34 | 139.52% | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 132 | n/a | n/a | 3 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 33 | 29.64 | 11.34% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 112 | 46.97 | 138.45% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 30 | n/a | n/a | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | n/a | n/a | 1 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 48 49 | n/a | n/a | 4 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 91 103 | n/a | n/a | 2 | Jul 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 135 | 125.9 | 7.23% | 1 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 240 | n/a | n/a | 2 | Jun 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 5 22 | n/a | n/a | 3 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 270 300 | 9.52 | 3051.26% | 2 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 40 | n/a | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 56 | n/a | n/a | 3 | Aug 6, 2018 |